What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Surgery
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Task force and Guideline.
His studies in Coronary artery disease, Cardiac catheterization, Angina, Randomized controlled trial and Odds ratio are all subfields of Internal medicine research.
His Coronary artery disease research also works with subjects such as
- Percutaneous coronary intervention which connect with Conventional PCI and Coronary artery bypass surgery,
- Radiology which is related to area like Fractional flow reserve.
His research in Myocardial infarction intersects with topics in Coronary arteries, Surgery, Cohort study and Angioplasty.
His Surgery research is multidisciplinary, incorporating perspectives in Risk factor, Confidence interval and Emergency medicine.
His Guideline study combines topics in areas such as Framingham Risk Score, Implantable cardioverter-defibrillator, Primary prevention, Family medicine and Physical therapy.
His most cited work include:
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons (2158 citations)
- American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) (1831 citations)
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (1638 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Surgery.
His work in Percutaneous coronary intervention, Angina, Heart failure, Revascularization and Randomized controlled trial are all subfields of Internal medicine research.
Mark A. Hlatky has included themes like Physical therapy and Clinical trial in his Randomized controlled trial study.
His work on Angioplasty as part of his general Cardiology study is frequently connected to Task force and In patient, thereby bridging the divide between different branches of science.
His research integrates issues of Odds ratio, Cohort study and Emergency medicine in his study of Myocardial infarction.
His work carried out in the field of Coronary artery disease brings together such families of science as Cardiac catheterization, Diabetes mellitus, Quality of life, Fractional flow reserve and Proportional hazards model.
He most often published in these fields:
- Internal medicine (57.87%)
- Cardiology (47.53%)
- Myocardial infarction (23.69%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (57.87%)
- Cardiology (47.53%)
- Myocardial infarction (23.69%)
In recent papers he was focusing on the following fields of study:
Mark A. Hlatky mostly deals with Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Guideline.
His studies deal with areas such as Diabetes mellitus and Surgery as well as Internal medicine.
His work on Percutaneous coronary intervention, Heart failure, Implantable cardioverter-defibrillator and Angioplasty as part of general Cardiology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Heart failure research incorporates elements of Demography and Intensive care medicine.
His Coronary artery disease research is multidisciplinary, incorporating perspectives in Quality of life, Fractional flow reserve, Revascularization, Type 2 diabetes and Angina.
His Guideline study which covers Primary prevention that intersects with Blood cholesterol and Ldl cholesterol.
Between 2014 and 2021, his most popular works were:
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (1434 citations)
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (637 citations)
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society (531 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
Mark A. Hlatky mainly investigates Internal medicine, Myocardial infarction, Cardiology, Guideline and Coronary artery disease.
Mark A. Hlatky combines topics linked to Surgery with his work on Internal medicine.
In general Cardiology, his work in Percutaneous coronary intervention is often linked to In patient linking many areas of study.
His Percutaneous coronary intervention research focuses on Conventional PCI and how it connects with Revascularization.
His Guideline study combines topics in areas such as Implantable cardioverter-defibrillator, Primary prevention, Ventricular tachycardia, Sudden cardiac arrest and Sudden cardiac death.
His Coronary artery disease study integrates concerns from other disciplines, such as Fractional flow reserve, Radiology, Computed tomography angiography and Kidney disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
